Biotech Celgene Ready to Take Off
Celgene was one of the best performers in the biotech group for 2013. So far this year the stock continues to perform well; during the January swoon, it barely budged. The current price is perched on the handle of a very deep cup/handle pattern, pulling back from the recent surge toward 170. This recent consolidation…
Details